For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Bekijk de site in het Nederlands

Hemophilia A is an X-linked inherited bleeding disorder that affects approximately 1 in 5,000 male live births. It is caused by a deficient plasma level of clotting Factor VIII. A deficiency in Factor VIII results in suboptimal thrombin generation and fragile blood clots that easily bleed. Corien Eckhardt focuses on the etiology and outcome of inhibitor development (the development of antibodies which inhibit Factor VIII) in non-severe hemophilia A.

Event details of Inhibitor development in non-severe hemophilia A
Date 17 September 2014
Time 14:00 -15:00
Location Agnietenkapel

C.L. Eckhardt Inhibitor Development in Nonsevere Hemophilia A.

Supervisor

Prof. T.W. Kuijpers

Co-supervisors

Dr C.J. Fijnvandraat
Dr M. Peters
Prof. P.W. Kamphuisen

Agnietenkapel

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam

Entrance

This event is open to the public.